Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?

Direct oral anticoagulants (DOAC) are currently the drug of choice for drug prevention of stroke or systemic embolism in patients with atrial fibrillation (AF). However, repeated ischemic stroke or systemic embolism and bleeding while on DOAC is still a challenging clinical phenomenon in the managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Péč, Martin Jozef, Brisudová, Kristína, Škorňová, Ingrid, Staško, Ján, Mokáň, Marián, Kubisz, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655219/
https://www.ncbi.nlm.nih.gov/pubmed/36362597
http://dx.doi.org/10.3390/jcm11216369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655219/
https://www.ncbi.nlm.nih.gov/pubmed/36362597
http://dx.doi.org/10.3390/jcm11216369

Ejemplares similares